Skip to Content

Notice

Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

ACTION:

Notice of meeting.

SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting for the Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID). This meeting is open to the public, limited only by the space available; the meeting room will accommodate up to 100 people. The public is also welcome to listen to the meeting by telephone, limited only by the number of ports Start Printed Page 49610available (50); the toll-free dial-in number is 1-877-951-7311, with a pass code of 2208740.

DATES:

The meeting will be held on December 6, 2017, 8:30 a.m. to 5:00 p.m., EST, and December 7, 2017, 8:30 a.m. to 12:00 p.m., EST.

ADDRESSES:

CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30329; also 1-877-951-7311, with a pass code of 2208740.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Robin Moseley, MAT, Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30329, Telephone (404) 639-4461; rrm1@cdc.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers.

Matters To Be Considered: The agenda will include discussions on priority issues for the national centers, including foodborne infections, advanced molecular detection, antimicrobial resistance, sexually transmitted diseases, and vaccination coverage. A report back from the Board's Food Safety Modernization Act Surveillance Working Group will also be given. Agenda items are subject to change as priorities dictate.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Claudette Grant

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention .

End Signature End Supplemental Information

[FR Doc. 2017-23336 Filed 10-25-17; 8:45 am]

BILLING CODE 4163-19-P